Carl Feldbaum
Director/Board Member at Bio Ventures for Global Health
Net worth: 443 775 $ as of 2024-03-30
Profile
Carl B.
Feldbaum was the founder of Palomar Corp.
(founded in 1993) and held the title of President from 1993 to 2005.
He is currently the Chairman of Bio Ventures for Global Health (since 2004) and the President of Biotechnology Innovation Organization (since 1993).
In his former positions, he served as Chairman of The Life Sciences Foundation, Director of Connetics Corp.
(2005-2006), Independent Director of Exelixis, Inc. (2007-2023), Non-Executive Director of Actelion Ltd.
(2005-2015), Director of Cardiff Oncology, Inc. (2014-2015), and Director of The Biotechnology Institute.
Mr. Feldbaum received his undergraduate degree from Princeton University and his graduate degree from The University of Pennsylvania Law School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
EXELIXIS, INC.
0.01% | 2023-04-20 | 18,701 ( 0.01% ) | 443 775 $ | 2024-03-30 |
Carl Feldbaum active positions
| Companies | Position | Start |
|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Corporate Officer/Principal | 2004-12-31 |
| Bio Ventures for Global Health | Director/Board Member | 2013-06-23 |
Former positions of Carl Feldbaum
| Companies | Position | End |
|---|---|---|
| EXELIXIS, INC. | Director/Board Member | 2023-05-30 |
| CARDIFF ONCOLOGY, INC. | Director/Board Member | 2015-11-12 |
| ACTELION | Director/Board Member | 2015-05-07 |
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Director/Board Member | 2006-12-28 |
| Palomar Corp. | Founder | 2004-12-31 |
Training of Carl Feldbaum
| Princeton University | Undergraduate Degree |
| The University of Pennsylvania Law School | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| EXELIXIS, INC. | Health Technology |
| CARDIFF ONCOLOGY, INC. | Health Technology |
| Private companies | 7 |
|---|---|
Connetics Corp.
Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Actelion Ltd.
 Actelion Ltd. Pharmaceuticals: MajorHealth Technology Actelion Ltd. develops, produces and markets pharmaceutical drugs. The firm engages in research, development, manufacturing, and distribution of pharmaceutical, biological, and diagnostic products. The company was founded by Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann on December 30, 1999 and is headquartered in Allschwil, Switzerland. | Health Technology |
| Bio Ventures for Global Health | |
The Biotechnology Institute
 The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services The Biotechnology Institute is a non-profit organization, which engages in designing and managing programs about biotechnology research. Its programs include BioGENEius Challenges, leadership awards, and Adopt-A-School. The company was founded in 1998 and is headquartered in Washington, DC. | Commercial Services |
| Palomar Corp. | |
The Life Sciences Foundation
 The Life Sciences Foundation Miscellaneous Commercial ServicesCommercial Services The Life Sciences Foundation engaged in education and biotechnology information dissemination. It collected and organized historical information to educate future innovators, to engage the general public, and to provide lay audiences with an understanding of life sciences and biotechnology. The company was founded by G. Steven Burrill, Dennis Gillings, John Lechleiter, Henri Termeer, and Arnold Thackray in 2010 and was headquartered in San Francisco, CA. | Commercial Services |
- Stock Market
- Insiders
- Carl Feldbaum
